Clinical Trial Update: To Elucidate the Effect of Mesenchymal Stem Cells on the T Cell Repertoire of the Kidney Transplant Patients [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating the impact of mesenchymal stem cells on the T cell repertoire in renal transplant recipients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Transplant Rejection

Drugs mentioned

• Mesenchymal stem cells (mesenchymal stem cells)

Snippet

Sponsor: Post Graduate Institute of Medical Education and Research, Chandigarh | Conditions: Renal Transplant Rejection | Phase 1 | Status: UNKNOWN